(Q34439267)

2 August 2017

1 reference

title

Current management of primary pulmonary hypertension. (English)

1 reference

2 August 2017

Klings ES

1

1 reference

PubMed ID

11708765

2 August 2017

Farber HW

series ordinal

2

1 reference

2 August 2017

1 January 2001

1 reference

2 August 2017

1 reference

2 August 2017

61

1 reference

2 August 2017

13

1 reference

2 August 2017

1945-1956

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200161130-00005

2 August 2017

0 references

cites work

Hemodynamic effects of Bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension

1 reference

12 December 2020

Short-term hemodynamic effect of a new oral PGI2 analogue, beraprost, in primary and secondary pulmonary hypertension

1 reference

12 December 2020

Sildenafil can increase the response to inhaled nitric oxide.

1 reference

12 December 2020

Viagra for impotence of pulmonary vasodilator therapy?

1 reference

12 December 2020

Electrocardiogram in primary pulmonary hypertension

1 reference

12 December 2020

Lung disease in systemic sclerosis (scleroderma).

1 reference

12 December 2020

Echocardiographic features of primary pulmonary hypertension

1 reference

12 December 2020

Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension

1 reference

12 December 2020

Deleterious effects of hydralazine in patients with pulmonary hypertension

1 reference

12 December 2020

Adenosine as a vasodilator in primary pulmonary hypertension

1 reference

12 December 2020

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

1 reference

12 December 2020

Primary pulmonary hypertension

1 reference

12 December 2020

Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards

1 reference

12 December 2020

Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension

1 reference

12 December 2020

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

1 reference

12 December 2020

Primary pulmonary hypertension. A national prospective study

1 reference

12 December 2020

The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension.

1 reference

12 December 2020

Primary pulmonary hypertension in HIV infection

1 reference

12 December 2020

Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension

1 reference

12 December 2020

Abnormal Pulmonary Artery Pressure Response in Asymptomatic Carriers of Primary Pulmonary Hypertension Gene

1 reference

12 December 2020

High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

1 reference

12 December 2020

Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group

1 reference

12 December 2020

Primary pulmonary hypertension

1 reference

12 December 2020

Primary pulmonary hypertension

1 reference

12 December 2020

Single lung transplantation for pulmonary hypertension. Single institution experience in 34 patients.

1 reference

12 December 2020

Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group

1 reference

12 December 2020

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

1 reference

12 December 2020

Acute hemodynamic responses to inhaled nitric oxide in patients with limited scleroderma and isolated pulmonary hypertension

1 reference

12 December 2020

Scleroderma. Clinical problems. The lungs

1 reference

12 December 2020

Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension

1 reference

12 December 2020

Prevalence of pulmonary hypertension in limited and diffuse scleroderma

1 reference

12 December 2020

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

1 reference

12 December 2020

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial

1 reference

12 December 2020

Captopril in primary pulmonary hypertension.

1 reference

12 December 2020

Pulmonary hypertension, "plexogenic pulmonary arteriopathy" and the appetite depressant drug aminorex: post or propter?

1 reference

12 December 2020

Combination therapy for pulmonary hypertension: a glimpse into the future?

1 reference

12 December 2020

Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.

1 reference

12 December 2020

Systemic sclerosis-associated pulmonary hypertension: short- and long-term effects of epoprostenol (prostacyclin)

1 reference

12 December 2020

Primary pulmonary hypertension: natural history and the importance of thrombosis

1 reference

12 December 2020

Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study.

1 reference

12 December 2020

Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application

1 reference

12 December 2020

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene

1 reference

12 December 2020

Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension

1 reference

12 December 2020

Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin)

1 reference

12 December 2020

Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics

1 reference

12 December 2020

Calcium channel blockers in primary pulmonary hypertension

1 reference

12 December 2020

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin

1 reference

12 December 2020

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

12 December 2020

Additive effect of beraprost on pulmonary vasodilation by inhaled nitric oxide in children with pulmonary hypertension

1 reference

12 December 2020

Prothrombotic mechanisms in primary pulmonary hypertension.

1 reference

12 December 2020

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

1 reference

12 December 2020

Pharmacodynamic profile of prostacyclin

1 reference

12 December 2020

Familial primary pulmonary hypertension

1 reference

12 December 2020

Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion

1 reference

12 December 2020

Magnetic resonance imaging provides evidence for remodeling of the right ventricle after single-lung transplantation for pulmonary hypertension.

1 reference

12 December 2020

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

1 reference

12 December 2020

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

1 reference

12 December 2020

10.2165/00003495-200161130-00005

Identifiers

DOI

1 reference

PubMed ID

11708765

Dimensions Publication ID

2 August 2017

0 references

1 reference

PubMed ID

11708765